Tech Company Financing Transactions
OSSIO Funding Round
MVM Life Science Partners and private investors participated in a $38.5 million Series C funding round for OSSIO. This venture round was announced on 10/18/2022.
Transaction Overview
Company Name
Announced On
10/18/2022
Transaction Type
Venture Equity
Amount
$38,500,000
Round
Series C
Investors
MVM Life Science Partners (Lead Investor)
Proceeds Purpose
The company intends to use the funds to strengthen awareness for the patient benefits of bio-integrative OSSIOfiber implants and accelerate new product platforms into the major orthopedic fixation markets.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
300 TradeCenter 3690
Woburn, MA 01801
USA
Woburn, MA 01801
USA
Phone
Undisclosed
Website
Email Address
Overview
OSSIO is an orthopedic fixation company committed to transforming the orthopedic experience for patients, physicians, and payors. Our vision is to provide the first credible replacement to metal implants in the $10B+ orthopedic fixation market (screws, pins, plates) with an Intelligent Bone Regeneration Technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Verrier
Chief Financial Officer
Moshe Shneor
Chief Medical Officer
Ronit Merchav-Feuermann
Chief Operating Officer
Brennan Marilla
Founder
Orahn Preiss-Bloom
Vice President
Dani Bar-Lev
VP - Regulatory Affairs
Taly Lindner
Browse more venture capital transactions:
Prev: 10/18/2022: Pivot Energy venture capital transaction
Next: 10/18/2022: Salu venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs